Evaluation of the Effects of Sodium–glucose Co‐transporter 2 Inhibition With Empagliflozin on Morbidity and Mortality in Patients With Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR‐Preserved Trial

European Journal of Heart Failure - United States
doi 10.1002/ejhf.1596
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Evaluation of the Effect of Sodium–glucose Co‐transporter 2 Inhibition With Empagliflozin on Morbidity and Mortality of Patients With Chronic Heart Failure and a Reduced Ejection Fraction: Rationale for and Design of the EMPEROR‐Reduced Trial

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Rationale and Design of the EMPERIAL-Preserved and EMPERIAL-Reduced Trials of Empagliflozin in Patients With Chronic Heart Failure

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Association Between Hyperuricemia and Mortality in Heart Failure Patients With Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2015English

Influence of Ejection Fraction on Cause-Specific Mortality in Heart Failure With Preserved Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2018English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2019English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Assessment of the Functional State of Left Heart in Patients With Chronic Heart Failure With Preserved Ejection Fraction

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy